Prescription weight loss medications, including GLP-1 agonists, orlistat, and Contrave, may be effective for some people. But other lifestyle changes are still necessary for long-term success.

Topiramate is a new anticonvulsant with ... patients experienced weight loss (range 1-10 kg; average, 3.4 kg). The most frequent side effects were paresthesia (39.6%); emotional disturbances ...

That translates to an average weight loss of about 50 pounds for those taking Zepbound, compared with an average weight loss of 33 pounds for those taking Wegovy. People taking Zepbound were also ...

The treatment achieved an average weight loss of 20.2% at 72 weeks in adults with obesity without diabetes, while its rival managed 13.7%. Eli Lilly stock has been rebounding since its early ...

The advent of GLP-1 weight-loss medications such as Wegovy and Zepbound has spurred debate as to whether the drugs' cost should be covered by Medicare, Medicaid and private insurers. Late last ...

Conditions that cause unexplained weight loss include overactive thyroid, inflammatory bowel disease, and depression. Because unintentional weight loss can happen due to various health conditions ...

Lilly reported that in a head-to-head study of Zepbound versus Wegovy, its own product resulted in greater weight loss for patients. People on Zepbound showed an average weight loss of about 20% ...